# PDSB (PDS Biotechnology Corporation) - SEC EDGAR Financial Statements

> PDS Biotechnology Corporation reported $18.57M in total assets and a net loss of $32.28M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/PDSB
- Markdown: https://convexityos.com/fundamentals/PDSB.md
- SEC CIK: 0001472091
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:52 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001472091&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$25.59M | Operating profit |
| Net Income | FY 2025 | -$32.28M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$0.45 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$27.75M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $15.25M | Total debt: $34K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $19.03M | $22.57M | $27.76M | $29.43M | $11.25M | $7.92M | $6.10M | $831K | $34.31M | $24.83M |
| Total Operating Expenses | $31.54M | $36.32M | $43.05M | $41.67M | $21.44M | $14.90M | $21.03M | $3.65M | $51.97M | $39.51M |
| **Operating Income** | -$31.54M | -$36.32M | -$43.05M | -$41.67M | -$21.44M | -$14.90M | -$21.03M | -$3.65M | -$51.97M | -$39.51M |
| **EBITDA** | -$31.52M | -$36.30M | -$43.03M | -$41.67M | -$21.43M | -$14.89M | -$20.94M | -$3.58M | -$51.78M | -$39.41M |
| Interest Income | $1.22M | $2.51M | $2.90M | $935K | $4.3K | $55K | $353K | $0 | -- | -- |
| Interest Expense | $5.34M | $4.67M | $4.21M | $1.32M | $0 | $0 | $34K | $3.6K | $2.18M | $1.20M |
| Income Before Tax | -$35.67M | -$38.48M | -$44.35M | -$42.05M | -$21.43M | -$14.85M | -$7.38M | -$3.84M | -$53.45M | -$40.67M |
| Income Tax Expense | -$1.17M | -$869K | -$1.41M | -$1.20M | -$4.52M | $0 | -$382K | $0 | -$2.59M | -$1.85M |
| **Net Income** | -$34.50M | -$37.61M | -$42.94M | -$40.85M | -$16.92M | -$14.85M | -$7.00M | -$3.84M | -$50.86M | -$38.82M |
| Basic EPS | -$0.74 | -$1.03 | -$1.39 | -$1.43 | -$0.66 | -$0.89 | -$1.44 | $1.15 | -- | -- |
| **Diluted EPS** | -$0.74 | -$1.03 | -$1.39 | -$1.43 | -$0.66 | -$0.89 | -$1.44 | $1.15 | -- | -- |
| Basic Shares Outstanding | 46.4M | 36.5M | 31.0M | 28.6M | 25.6M | 16.7M | 4.9M | 3.3M | 1.5M | 1.4M |
| Diluted Shares Outstanding | 46.4M | 36.5M | 31.0M | 28.6M | 25.6M | 16.7M | 4.9M | 3.3M | 1.5M | 1.4M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $2.05M | $3.27M | $3.46M | $4.41M | $4.58M | $4.21M | $5.83M | $4.53M |
| Total Operating Expenses | $5.90M | $6.50M | $6.52M | $6.67M | $8.14M | $7.62M | $9.11M | $7.36M |
| **Operating Income** | -$5.90M | -$6.50M | -$6.52M | -$6.67M | -$8.14M | -$7.62M | -$9.11M | -$7.36M |
| **EBITDA** | -$5.89M | -$6.49M | -$6.52M | -$6.67M | -$8.13M | -$7.62M | -$9.10M | -$7.36M |
| Interest Income | $42K | $125K | $187K | $225K | $281K | $334K | $378K | $504K |
| Interest Expense | $1.77M | $3.38M | $1.01M | $1.11M | $1.15M | $2.14M | $931K | $1.10M |
| Income Before Tax | -$7.62M | -$9.75M | -$7.35M | -$7.56M | -$9.01M | -$9.43M | -$9.66M | -$7.95M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | -$1.17M | $0 |
| **Net Income** | -$7.62M | -$9.75M | -$7.35M | -$7.56M | -$9.01M | -$9.43M | -$8.49M | -$7.95M |
| Basic EPS | -$0.11 | -$0.18 | -$0.13 | -- | -$0.19 | -$0.21 | -$0.21 | -- |
| **Diluted EPS** | -$0.11 | -$0.18 | -$0.13 | -- | -$0.19 | -$0.21 | -$0.21 | -- |
| Basic Shares Outstanding | 71.9M | 55.7M | 55.5M | -- | 46.9M | 45.9M | 40.5M | -- |
| Diluted Shares Outstanding | 71.9M | 55.7M | 55.5M | -- | 46.9M | 45.9M | 40.5M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $26.71M | $41.69M | $56.56M | $73.82M | $65.24M | $28.84M | $12.16M | $104K | $88.07M | $106.4M |
| **Cash & Short-Term Investments** | $26.71M | $41.69M | $56.56M | $73.82M | $65.24M | $28.84M | $12.16M | $104K | $88.07M | $106.4M |
| **Total Current Assets** | $28.25M | $45.05M | $59.06M | $76.48M | $66.84M | $30.34M | $14.47M | $122K | $89.05M | $107.4M |
| Property, Plant & Equipment, Net | $120K | $142K | $134K | $0 | $86 | $5.4K | $21K | $30K | $3.42M | $3.42M |
| Intangible Assets | -- | -- | -- | -- | -- | $2.97M | $2.97M | $0 | -- | -- |
| Other Non-Current Assets | -- | -- | -- | -- | -- | -- | $0 | $13K | $143K | $143K |
| **Total Non-Current Assets** | $2.24M | $304K | $335K | $528K | $358K | $553K | $21K | $42K | $3.57M | $3.56M |
| **Total Assets** | $30.49M | $45.36M | $59.39M | $77.01M | $67.20M | $30.89M | $14.49M | $164K | $92.62M | $110.9M |
| Accounts Payable | $3.57M | $1.68M | $6.98M | $1.22M | $1.31M | $1.42M | $1.20M | $1.31M | $4.37M | $3.47M |
| **Total Current Liabilities** | $9.48M | $17.09M | $13.63M | $9.82M | $3.76M | $3.27M | $2.79M | $1.91M | $12.87M | $6.68M |
| **Total Non-Current Liabilities** | $11.76M | $9.27M | $19.63M | $23.18M | $231K | $490K | $0 | $321K | $80.36M | $14.95M |
| **Total Liabilities** | $21.24M | $26.35M | $33.26M | $33.01M | $3.99M | $3.76M | $2.79M | $2.23M | $93.23M | $21.64M |
| **Total Debt (incl. Leases)** | $62K | $123K | $179K | $452K | $490K | $610K | -- | -- | -- | -- |
| Common Stock | $18K | $13K | $11K | $10.0K | $9.4K | $7.3K | $1.7K | $1.1K | $10K | $9.8K |
| Retained Earnings | -$216.6M | -$182.1M | -$144.5M | -$101.6M | -$60.70M | -$43.79M | -$28.94M | -$21.94M | -$151.9M | -$101.1M |
| **Total Stockholders' Equity** | $9.25M | $19.00M | $26.13M | $44.00M | $63.21M | $27.13M | $11.70M | -$2.07M | -$610K | $89.28M |
| Total Equity | $9.25M | $19.00M | $26.13M | $44.00M | $63.21M | $27.13M | $11.70M | -$2.07M | -$610K | $89.28M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $15.25M | $5.60M | $21.66M | $26.71M | $26.20M | $31.87M | $39.98M | $41.69M |
| **Cash & Short-Term Investments** | $15.25M | $5.60M | $21.66M | $26.71M | $26.20M | $31.87M | $39.98M | $41.69M |
| **Total Current Assets** | $18.37M | $7.05M | $22.89M | $28.25M | $27.89M | $33.65M | $42.47M | $45.05M |
| Property, Plant & Equipment, Net | $168K | $177K | $115K | $120K | $126K | $131K | $137K | $142K |
| **Total Non-Current Assets** | $198K | $1.76M | $1.78M | $2.24M | $6.81M | $6.83M | $4.56M | $304K |
| **Total Assets** | $18.57M | $8.81M | $24.66M | $30.49M | $34.71M | $40.48M | $47.03M | $45.36M |
| Accounts Payable | $2.99M | $6.39M | $3.65M | $3.57M | $5.18M | $4.50M | $2.86M | $1.68M |
| **Total Current Liabilities** | $5.08M | $12.38M | $10.15M | $9.48M | $13.33M | $11.53M | $18.27M | $17.09M |
| **Total Non-Current Liabilities** | $1.1K | $9.5K | $10.62M | $11.76M | $11.92M | $12.98M | $6.40M | $9.27M |
| **Total Liabilities** | $5.08M | $12.39M | $20.77M | $21.24M | $25.25M | $24.52M | $24.67M | $26.35M |
| **Total Debt (incl. Leases)** | $34K | $41K | $49K | $62K | $78K | $93K | $108K | $123K |
| Common Stock | $34K | $18K | $18K | $18K | $16K | $15K | $15K | $13K |
| Retained Earnings | -$241.3M | -$233.7M | -$224.0M | -$216.6M | -$209.0M | -$200.0M | -$190.6M | -$182.1M |
| **Total Stockholders' Equity** | $13.50M | -$3.58M | $3.89M | $9.25M | $9.45M | $15.96M | $22.36M | $19.00M |
| Total Equity | $13.50M | -$3.58M | $3.89M | $9.25M | $9.45M | $15.96M | $22.36M | $19.00M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$34.50M | -$37.61M | -$42.94M | -$40.85M | -$16.92M | -$14.85M | -$7.00M | -$3.84M | -$50.86M | -$38.82M |
| Depreciation & Amortization | $22K | $21K | $17K | $86 | $5.4K | $16K | $98K | $69K | $183K | $100K |
| Stock-Based Compensation | $4.11M | $6.85M | $7.61M | $5.20M | $4.07M | $432K | $3.14M | $867K | $6.18M | $5.31M |
| Change in Payables | $1.89M | -$5.30M | $5.76M | -$90K | -$106K | $218K | -$1.98M | $789K | $898K | $1.42M |
| **Operating Cash Flow** | -$27.75M | -$35.03M | -$33.64M | -$25.71M | -$12.49M | -$13.15M | -$18.07M | -$1.57M | -$40.70M | -$32.19M |
| Capital Expenditure | $0 | -$29K | $0 | -- | -- | -- | -- | $0 | -$189K | -$687K |
| **Free Cash Flow** | -$27.75M | -$35.06M | -$33.64M | -- | -- | -- | -- | -$1.57M | -$40.89M | -$32.88M |
| **Investing Cash Flow** | $0 | -$29K | $0 | -- | -- | $0 | $29.38M | $0 | -$189K | -$687K |
| Common Stock Issued | $9.71M | $0 | $16.13M | $9.86M | $48.54M | $29.76M | $750K | $1.28M | -- | -- |
| **Financing Cash Flow** | $12.77M | $20.19M | $16.38M | $34.29M | $48.89M | $29.83M | $750K | $1.50M | $22.55M | $9.08M |
| **Net Change in Cash** | -$14.98M | -$14.87M | -$17.26M | $8.58M | $36.40M | $16.68M | $12.06M | -$53.42M | -$18.33M | -$23.79M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$7.62M | -$9.75M | -$7.35M | -$7.56M | -$9.01M | -$9.43M | -$8.49M | -$7.95M |
| Depreciation & Amortization | $8.4K | $8.4K | $5.5K | $5.5K | $5.5K | $5.5K | $5.5K | $5.5K |
| Stock-Based Compensation | $840K | $1.13M | $1.16M | $1.16M | $1.25M | $448K | $1.25M | $1.64M |
| Change in Payables | -$3.40M | $2.74M | $76K | -$1.61M | $683K | $1.64M | $1.17M | $384K |
| **Operating Cash Flow** | -$8.22M | -$2.79M | -$4.37M | -$3.70M | -$5.92M | -$9.10M | -$9.03M | -$8.23M |
| Common Stock Issued | $2.51M | $0 | $0 | $2.71M | $0 | $0 | $6.99M | $0 |
| **Financing Cash Flow** | $17.87M | -$13.27M | -$680K | $4.22M | $241K | $996K | $7.32M | $173K |
| **Net Change in Cash** | $9.65M | -$16.06M | -$5.05M | $513K | -$5.67M | -$8.11M | -$1.71M | -$8.06M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -372.9% | -197.9% | -164.3% | -92.8% | -26.8% | -54.7% | -59.8% | -- | -- | -43.5% |
| Return on Assets (ROA) | -113.1% | -82.9% | -72.3% | -53.1% | -25.2% | -48.1% | -48.3% | -2333.2% | -54.9% | -35.0% |
| Current Ratio | 2.98x | 2.64x | 4.33x | 7.79x | 17.80x | 9.28x | 5.18x | 0.06x | 6.92x | 16.06x |
| Quick Ratio | 2.82x | 2.44x | 4.15x | 7.52x | 17.37x | 8.82x | 4.35x | 0.05x | 6.84x | 15.92x |
| Debt to Equity | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.02x | -- | -- | -- | -- |
| EPS Growth (YoY) | -- | -- | -- | -- | -- | -- | -225.2% | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -239.2% | -- | -856.9% | -372.9% | -369.0% | -229.3% | -158.7% | -197.9% |
| Return on Assets (ROA) | -173.8% | -382.3% | -135.2% | -113.1% | -100.5% | -90.4% | -75.5% | -82.9% |
| Current Ratio | 3.62x | 0.57x | 2.26x | 2.98x | 2.09x | 2.92x | 2.33x | 2.64x |
| Quick Ratio | 3.00x | 0.45x | 2.13x | 2.82x | 1.97x | 2.76x | 2.19x | 2.44x |
| Debt to Equity | 0.00x | -- | 0.01x | 0.01x | 0.01x | 0.01x | 0.00x | 0.01x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
